Fingolimod Capsule
Product Images NDC 82009-143

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 82009-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fingolimod Chemical Structure (Figure1)

FDA Label Image

Figure 1 Time To 3-month Confirmed Disability Progression ? Study 1 (itt Population) (Figure2)

FDA Label Image

Bottle-image (Bottle Label 0.5mg Jpeg)

Bottle-image (Bottle Label 0.5mg Jpeg)
This text provides information about a medication containing 0.56 mg of fingolimod in each capsule, with a National Drug Code (NDC) number of 82000-143-30. The usual dosage should be checked in the package insert. The manufacturer mentioned is Iocon Pharma Limited from Bengaluru, India. The package is child-resistant, and it is advised to keep all drugs out of the reach of children. The text also includes batch serialization coding details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.